Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery.

Remus JL, Dantzer R.

Int J Neuropsychopharmacol. 2016 Sep;19(9). pii: pyw028. doi: 10.1093/ijnp/pyw028. Review.


Polyunsaturated fatty acids moderate the effect of poor sleep on depression risk.

Lotrich FE, Sears B, McNamara RK.

Prostaglandins Leukot Essent Fatty Acids. 2016 Mar;106:19-25. doi: 10.1016/j.plefa.2015.10.004.


High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity.

Fitzgibbon M, Finn DP, Roche M.

Int J Neuropsychopharmacol. 2015 Sep 5;19(3):pyv095. doi: 10.1093/ijnp/pyv095. Review.


Measuring sickness behavior in the context of pancreatic cancer.

Tobias K, Rosenfeld B, Pessin H, Breitbart W.

Med Hypotheses. 2015 Mar;84(3):231-7. doi: 10.1016/j.mehy.2015.01.002.


A dialogue between the immune system and brain, spoken in the language of serotonin.

Baganz NL, Blakely RD.

ACS Chem Neurosci. 2013 Jan 16;4(1):48-63. doi: 10.1021/cn300186b. Review.


Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

Loftis JM, Patterson AL, Wilhelm CJ, McNett H, Morasco BJ, Huckans M, Morgan T, Saperstein S, Asghar A, Hauser P.

J Psychosom Res. 2013 Jan;74(1):57-63. doi: 10.1016/j.jpsychores.2012.10.012.


Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C).

Birerdinc A, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM.

Brain Behav. 2012 Sep;2(5):525-31. doi: 10.1002/brb3.72.


Gene expression biomarkers of response to citalopram treatment in major depressive disorder.

Mamdani F, Berlim MT, Beaulieu MM, Labbe A, Merette C, Turecki G.

Transl Psychiatry. 2011 Jun 21;1:e13. doi: 10.1038/tp.2011.12.


Risk factors for the development of depression in patients with hepatitis C taking interferon-α.

Smith KJ, Norris S, O'Farrelly C, O'Mara SM.

Neuropsychiatr Dis Treat. 2011;7:275-92. doi: 10.2147/NDT.S13917.


Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders.

Kelley KW, Dantzer R.

Brain Behav Immun. 2011 Jun;25 Suppl 1:S13-20. doi: 10.1016/j.bbi.2010.12.013. Review.


Inflammation-associated depression: from serotonin to kynurenine.

Dantzer R, O'Connor JC, Lawson MA, Kelley KW.

Psychoneuroendocrinology. 2011 Apr;36(3):426-36. doi: 10.1016/j.psyneuen.2010.09.012. Review.


No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C.

Kronfol Z, Litman HJ, Back-Madruga C, Bieliauskas LA, Lindsay KL, Lok AS, Fontana RJ; HALT-C Trial Group..

J Affect Disord. 2011 Mar;129(1-3):205-12. doi: 10.1016/j.jad.2010.09.010.


Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment.

Franzen PL, Buysse DJ, Rabinovitz M, Pollock BG, Lotrich FE.

Psychiatry Res. 2010 May 15;177(1-2):240-5. doi: 10.1016/j.psychres.2009.02.011.


HIV/Hepatitis C virus-coinfected virologic responders to pegylated interferon and ribavirin therapy more frequently incur interferon-related adverse events than nonresponders do.

Osinusi A, Rasimas JJ, Bishop R, Proschan M, McLaughlin M, Murphy A, Cortez KJ, Polis MA, Masur H, Rosenstein D, Kottilil S.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):357-63. doi: 10.1097/QAI.0b013e3181c7a29d.


Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.

Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD.

Biol Psychiatry. 2009 Sep 1;66(5):407-14. doi: 10.1016/j.biopsych.2009.03.015.


Cytokine, sickness behavior, and depression.

Dantzer R.

Immunol Allergy Clin North Am. 2009 May;29(2):247-64. doi: 10.1016/j.iac.2009.02.002.


Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.

Fontana RJ, Kronfol Z, Lindsay KL, Bieliauskas LA, Padmanabhan L, Back-Madruga C, Lok AS, Stoddard AM; HALT-C Trial Group..

Am J Gastroenterol. 2008 Nov;103(11):2766-75. doi: 10.1111/j.1572-0241.2008.02106.x.


Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.

Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C, Miyazaki C, Alexander N, Hotopf M, Cleare AJ, Norris S, Cassidy E, Aitchison KJ, Miller AH, Pariante CM.

Mol Psychiatry. 2009 Dec;14(12):1095-104. doi: 10.1038/mp.2008.48.

Items per page

Supplemental Content

Support Center